The FDA Law Blog
FEBRUARY 28, 2023
THC acetate esters are different than delta-9-THC, the psychoactive compound found naturally in the cannabis plant. Dr. Boos explained that delta-9-THCO and delta-8-THCO have similar chemical structures and pharmacological activities as compounds in the cannabis plant so they fall within the definition of THC. Terrence L. Boos, Ph.D.,
Omnicell
SEPTEMBER 5, 2022
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 16, 2021
The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma. Beckley – formerly known as Beckley Canopy Therapeutics – raised £7.4
European Pharmaceutical Review
OCTOBER 27, 2022
Since 2018, employment numbers in the industry have grown by 11 percent, totalling $2.9 To date, 747 novel compounds are in production. The investigation identified that in the pandemic, the economy reduced 1.5 percent of its workforce. trillion dollars in 2021. Sluggish economic growth.
pharmaphorum
OCTOBER 31, 2022
. “We are proud to be not just one of the few AI-driven biotech companies to have made it to the clinical stage, but also one of the first to bring forward a novel clinical compound against a novel target, that was entirely discovered and developed internally on our platform,” said Zhang, who acts as Verge’s chief executive.
pharmaphorum
FEBRUARY 3, 2022
It said the medical cannabis market in Germany is valued at approximately €122 million, growing at around 25% last year and with a compound annual growth rate estimated at 55 % since the market was liberalised in 2017. The two drugs were developed by medical cannabis pioneer GW Pharma, which was acquired by Jazz last year.
pharmaphorum
JANUARY 11, 2023
Anima uses its mRNA Lightning platform to discover small molecules and determine their mechanisms of action for diseases previously deemed undruggable, with scientists searching for compounds that target proteins with roles in regulating mRNA, so as to affect disease states through post-transcriptional regulation (i.e.
Expert insights. Personalized for you.
58 
Let's personalize your content